Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors

被引:48
|
作者
Cheng, Ming-Fu [1 ]
Hung, Ming-Shiu [1 ]
Song, Jen-Shin [1 ]
Lin, Shu-Yu [1 ]
Liao, Fang-Yu [1 ]
Wu, Mine-Hsine [1 ]
Hsiao, Wenchi [1 ]
Hsieh, Chia-Ling [1 ]
Wu, Jian-Sung [1 ]
Chao, Yu-Sheng [1 ]
Shih, Chuan [1 ]
Wu, Su-Ying [1 ]
Ueng, Shau-Hua [1 ]
机构
[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan 35053, Miaoli County, Taiwan
关键词
Sulfonylhydrazide; Indoleamine 2,3-dioxygenase; Structure-activity relationship; Molecular docking; CANCER-IMMUNOTHERAPY; DERIVATIVES; INDOLEAMINE-2,3-DIOXYGENASE; BLOCKADE; TARGET; PD-1;
D O I
10.1016/j.bmcl.2014.05.084
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of phenyl benzenesulfonylhydrazides has been identified as potent inhibitors of indoleamine 2,3-dioxygenase (IDO), and their structure-activity relationship was explored. Coupling reactions between various benzenesulfonyl chlorides and phenylhydrazides were utilized to synthesize the sulfonylhydrazides bearing various substituents. Compound 3i exhibited 61 nM of IC50 in enzymatic assay and 172 nM of EC50 in the HeLa cell. The computational study of 3i suggested that the major interactions between 3i and IDO protein are the coordination of sulfone and heme iron, the hydrogen bonding and hydrophobic interactions between 3i and IDO. This novel class of IDO inhibitor provides a new direction to discover effective anti-cancer agents. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3403 / 3406
页数:4
相关论文
共 50 条
  • [21] Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation
    Carvalho, Catarina
    Siegel, David
    Inman, Martyn
    Xiong, Rui
    Ross, David
    Moody, Christopher J.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, 12 (17) : 2663 - 2674
  • [22] Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors
    Jin, Fangfang
    Hu, Qiyue
    Fei, Hongbo
    Lv, Hejun
    Wang, Shenglan
    Gui, Bin
    Zhang, Junzhen
    Tu, Wangyang
    Zhang, Yun
    Zhang, Lei
    Wan, Hong
    Zhang, Limin
    Hu, Bin
    Yang, Fanglong
    Bai, Chang
    He, Feng
    Zhang, Lianshan
    Tao, Weikang
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (02): : 195 - 201
  • [23] Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO)
    Pan, Shulei
    Zhou, Yangli
    Wang, Qiusheng
    Wang, Yanlin
    Tian, Chenyu
    Wang, Tianqi
    Huang, Luyi
    Nan, Jinshan
    Li, Linli
    Yang, Shengyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
  • [24] A Powerful Yeast-Based Screening Assay for the Identification of Inhibitors of Indoleamine 2,3-Dioxygenase
    Cerejo, Marta
    Andrade, Goncalo
    Roca, Christophe
    Sousa, Jose
    Rodrigues, Catia
    Pinheiro, Ricardo
    Chatterjee, Sukalyan
    Vieira, Helena
    Calado, Patricia
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (10) : 1362 - 1371
  • [25] IDENTIFICATION OF A NOVEL INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR BEARING AN EIGHT-MEMBERED RING FUSED INDOLE SCAFFOLD AND ITS STRUCTURE-ACTIVITY RELATIONSHIP
    Yamaguchi, Ayuta
    Inuki, Shinsuke
    Ohta, Katsumi
    Oishi, Shinya
    Asai, Akira
    Ohno, Hiroaki
    HETEROCYCLES, 2021, 103 (01) : 331 - 347
  • [26] 1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2)
    Rohrig, Ute F.
    Majjigapu, Somi Reddy
    Caldelari, Daniela
    Dilek, Nahzli
    Reichenbach, Patrick
    Ascencao, Kelly
    Irving, Melita
    Coukos, George
    Vogel, Pierre
    Zoete, Vincent
    Michielin, Olivier
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 4330 - 4333
  • [27] A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA
    Yen, Meng-Chi
    Lin, Chi-Chen
    Chen, Yi-Ling
    Huang, Shih-Shien
    Yang, Huei-Jiun
    Chang, Chih-Peng
    Lei, Huan-Yao
    Lai, Ming-Derg
    CLINICAL CANCER RESEARCH, 2009, 15 (02) : 641 - 649
  • [28] Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO-1) Inhibitors Based on Ortho-Naphthaquinone-Containing Natural Product
    Zhao, Hongchuan
    Sun, Pu
    Guo, Wei
    Wang, Yi
    Zhang, Ao
    Meng, Linghua
    Ding, Chunyong
    MOLECULES, 2019, 24 (06)
  • [29] Marine Natural Products and Other Derivatives as Potent Indoleamine 2,3-Dioxygenase Inhibitors
    Delfourne, Evelyne
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (10) : 988 - 996
  • [30] Synthesis of 4-and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase
    Balti, Monaem
    Plas, Aurelie
    Meinguet, Celine
    Haufroid, Marie
    Themans, Quentin
    Efrit, Mohamed Lotfi
    Wouters, Johan
    Lanners, Steve
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3607 - 3610